Parallax Volatility Advisers
EW icon

Parallax Volatility Advisers’s Edwards Lifesciences EW Stock Holding History

Parallax Volatility Advisers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$573 – 1732
2024
Q4 		$592 Buy
+8
New +$560 ﹤0.01% 1915
2024
Q3 		– Sell
-2,265
Closed -$165K – 2096
2024
Q2 		$209K Sell
2,265
-14,032
-86% -$1.24M ﹤0.01% 1600
2024
Q1 		$1.56M Buy
+16,297
New +$1.37M ﹤0.01% 1104
2023
Q1 		– Sell
-2,068
Closed -$163K – 2841
2022
Q4 		$154K Buy
+2,068
New +$159K ﹤0.01% 2194
2021
Q4 		– Sell
-121,376
Closed -$14.2M – 3114
2021
Q3 		$13.7M Buy
121,376
+94,350
+349% +$10.8M 0.01% 799
2021
Q2 		$2.8M Buy
+27,026
New +$2.55M ﹤0.01% 1504
2021
Q1 		– Sell
-15,374
Closed -$1.4M – 3364
2020
Q4 		$1.4M Sell
15,374
-5,378
-26% -$446K ﹤0.01% 2038
2020
Q3 		$1.66M Sell
20,752
-23,565
-53% -$1.84M ﹤0.01% 1777
2020
Q2 		$3.06M Sell
44,317
-26,987
-38% -$1.92M ﹤0.01% 1292
2020
Q1 		$4.48M Buy
71,304
+66,576
+1,408% +$4.8M 0.01% 906
2019
Q4 		$368K Buy
4,728
+1,599
+51% +$125K ﹤0.01% 1845
2019
Q3 		$229K Buy
+3,129
New +$220K ﹤0.01% 1822
2019
Q2 		– Sell
-370,647
Closed -$23.6M – 2851
2019
Q1 		$23.6M Buy
370,647
+365,754
+7,475% +$20.9M 0.03% 284
2018
Q4 		$250K Buy
4,893
+1,014
+26% +$51.3K ﹤0.01% 1687
2018
Q3 		$225K Sell
3,879
-47,955
-93% -$2.35M ﹤0.01% 1596
2018
Q2 		$2.52M Buy
51,834
+29,265
+130% +$1.37M ﹤0.01% 827
2018
Q1 		$1.05M Buy
22,569
+7,056
+45% +$306K ﹤0.01% 952
2017
Q4 		$583K Buy
+15,513
New +$569K ﹤0.01% 1435
2016
Q3 		– Sell
-91,902
Closed -$3.46M – 3109
2016
Q2 		$3.06M Buy
+91,902
New +$3.14M 0.01% 781
2015
Q1 		– Sell
-8,496
Closed -$180K – 4645
2014
Q4 		$180K Buy
+8,496
New +$171K ﹤0.01% 2950

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Parallax Volatility Advisers's EW Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 8 shares — an estimated $573 sold.

Parallax Volatility Advisers first reported a position in EW in Q4 2014 and held it in 20 quarters. The position peaked at $23.6M in Q1 2019. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8 Edwards Lifesciences shares in Q1 2025, an estimated $573.
  • Parallax Volatility Advisers first reported a position in Edwards Lifesciences in Q4 2014 and held it in 20 quarters.
  • Parallax Volatility Advisers's Edwards Lifesciences position peaked at $23.6M in Q1 2019.
  • 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.